Economic burden of chronic obstructive pulmonary disease

Respirology

Volumn 17, Issue 1, 2012, Pages 120-126

  Teo, W S Kelvin ^a   Tan, Woan Shin ^a   Chong, Wai Fung ^a   Abisheganaden, John ^b   Lew, Yii Jen ^c   Lim, Tow Keang ^d   Heng, Bee Hoon ^a  

^a NATIONAL HEALTHCARE GROUP   (Singapore)

^b TAN TOCK SENG HOSPITAL   (Singapore)

^c NATIONAL HEALTHCARE GROUP POLYCLINICS   (Singapore)

^d NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

chronic obstructive pulmonary disease; disease burden; economics; weighted attribution

Indexed keywords

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DATA EXTRACTION; EMERGENCY CARE; HEALTH CARE COST; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HOSPITAL ADMISSION; HOSPITAL PATIENT; HOSPITALIZATION COST; HUMAN; MAJOR CLINICAL STUDY; OUTPATIENT CARE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SINGAPORE;

ADULT; CARDIOVASCULAR DISEASES; COMORBIDITY; DIRECT SERVICE COSTS; FEMALE; HEALTH CARE COSTS; HOSPITAL COSTS; HUMANS; LONG-TERM CARE; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; PUBLIC HEALTH; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY TRACT INFECTIONS; SINGAPORE;

EID: 84255161087     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2011.02073.x     Document Type: Article

References (34)

1. Buist AS, McBurnie MA, Vollmer WM, et al,. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet 2007; 370: 741-50. (Pubitemid 47321907)
2. World Health Organization. Chronic respiratory diseases, burden. WHO, 2008. [Accessed 25 May 2011] Available from URL
3. World Health Organization. World Health Statistics, 2008. WHO, 2008. Available from URL:.
4. Lopez AD, Ezzati M, Jamison DT, et al,. Global Burden of Disease and Risk Factors. Oxford University Press and The World Bank, New York, 2006.
5. Tan WC, Seale JP, Charaoenratanakul S, et al,., the Members of Regional COPD Working Group. COPD prevalence in 12 Asia-Pacific countries and regions: projections based on the COPD prevalence estimation model. Respirology 2003; 8: 192-8. (Pubitemid 36749702)
6. Ng TP, Niti M, Tan WC,. Trends and ethnic differences in COPD hospitalization and mortality in Singapore. COPD 2004; 1: 5-11.
7. Ministry of Health, Singapore. Health Facts Singapore-Principal Causes of Death. MOH, 2009. [Accessed 25 May 2011] Available from URL
8. Ministry of Health, Singapore. Health Facts Singapore-Top 10 Conditions of Hospitalisation. MOH, 2009. [Accessed 25 May 2011] Available from URL
9. Ministry of Health, Singapore. National Health Survey. MOH, 2004. [Accessed 25 May 2011] Available from URL
10. Ministry of Community Development, Youth and Sports. Committee on Ageing Issues Report on the Ageing Population. MCYS, 2006. [Accessed 25 May 2011] Available from URL
11. Wouters EF,. Economic analysis of the confronting COPD survey: an overview of results. Respir. Med. 2003; 97 (Suppl. C): S3-14. (Pubitemid 36266865)
12. Nishimura S, Zaher C,. Cost impact of COPD in Japan: opportunities and challenges? Respirology 2004; 9: 466-73. (Pubitemid 40179751)
13. Chiang CH,. Cost analysis of chronic obstructive pulmonary disease in a tertiary care setting in Taiwan. Respirology 2008; 13: 689-94.
14. Tobacco Free Initiative-WHO (World Health Organization), HNP (Health Nutrition and Population Family)-The World Bank. An Economic Analysis of Tobacco Control in Thailand: Sarntisart I, 2003.
15. He QY, Zhou X, Xie CM, et al,. Impact of chronic obstructive pulmonary disease on quality of life and economic burden in Chinese urban areas. Zhonghua Jie He He Hu Xi Za Zhi 2009; 32: 253-7.
16. Ward M, Javitz H, Smith W, et al,. A comparison of three approaches for attributing hospitalizations to specific diseases in cost analyses. Int. J. Technol. Assess. Health Care 2000; 16: 125-36. (Pubitemid 30263208)
17. Sin DD, Anthonisen NR, Soriano JB, et al,. Mortality in COPD: role of comorbidities. Eur. Respir. J. 2006; 28: 1245-57. (Pubitemid 44883863)
18. Ministry of Health, Singapore. Healthcare Services-Primary Care. MOH, 2011. [Accessed 25 May 2011] Available from URL
19. Mascarenhas J, Lourenco P, Lopes R, et al,. Chronic obstructive pulmonary disease in heart failure. Prevalence, therapeutic and prognostic implications. Am. Heart J. 2008; 155: 521-5. (Pubitemid 351255605)
20. Steinacher REJ, Strohmer B, Pichler M, et al,. Heart failure and COPD: spirometric screening for COPD in an outpatient heart failure clinic. ESC Congress, 2008.
21. Wongsurakiat P, Maranetra KN, Wasi C, et al,. Acute respiratory illness in patients with COPD and the effectiveness of influenza vaccination: a randomized controlled study. Chest 2004; 125: 2011-20. (Pubitemid 38788164)
22. Silver H, Blanchette CM, Roberts M, et al,. Prevalence of comorbidities in patients hospitalized for COPD exacerbations and impact on inpatient mortality and hospital expenditures. Am. J. Respir. Crit. Care Med. 2010; 181: A5943.
23. Shaya FT, Dongyi D, Akazawa MO, et al,. Burden of concomitant asthma and COPD in a Medicaid population. Chest 2008; 134: 14-9. (Pubitemid 352008758)
24. Gerdtham UG, Andersson LF, Ericsson A, et al,. Factors affecting chronic obstructive pulmonary disease (COPD)-related costs: a multivariate analysis of a Swedish COPD cohort. Eur. J. Health Econ. 2009; 10: 217-26.
25. Chumney EC, Biddle AK, Simpson KN, et al,. The effect of cost construction based on either DRG or ICD-9 codes or risk group stratification on the resulting cost-effectiveness ratios. Pharmacoeconomics 2004; 22: 1209-16. (Pubitemid 40075722)
26. Singapore Department of Statistics. Yearbook of Statistics. Singapore Department of Statistics, Singapore, 2010.
27. Monetary Authority of Singapore. Financial Databases, Exchange Rates. MAS, 2009. [Accessed 25 May 2011] Available from URL
28. Ward MM, Javitz HS, Smith WM, et al,. Direct medical cost of chronic obstructive pulmonary disease in the U.S.A. Respir. Med. 2000; 94: 1123-9.
29. Peytremann-Bridevaux I, Staeger P, Bridevaux PO, et al,. Effectiveness of chronic obstructive pulmonary disease-management programs: systematic review and meta-analysis. Am. J. Med. 2008; 121: 433-43.
30. Einarsdottir K, Preen DB, Emery JD, et al,. Regular primary care lowers hospitalisation risk and mortality in seniors with chronic respiratory diseases. J. Gen. Intern. Med. 2010; 25: 766-73.
31. Tan WC, Ng TP,. COPD in Asia: where East meets West. Chest 2008; 133: 517-27. (Pubitemid 351272413)
32. Segel JE,. RTI-UNC Center of Excellence in Health Promotion Economics. Cost of Illness Studies-A Primer. RTI International, 2002. [Accessed 25 May 2011] Available from URL
33. Earnest A, Chen MI, Seow E,. Exploring if day and time of admission is associated with average length of stay among inpatients from a tertiary hospital in Singapore: an analytic study based on routine admission data. BMC Health Serv. Res. 2006; 6: 1-8.
34. Toh MP, Leong HS, Lim BK,. Development of a diabetes registry to improve quality of care in the National Healthcare Group in Singapore. Ann. Acad. Med. Singapore 2009; 38: 546-6.